<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Acrux Ltd — News on 6ix</title>
<link>https://6ix.com/company/acrux-ltd</link>
<description>Latest news and press releases for Acrux Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 06:25:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/acrux-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836616d78dffbe2df15bfa0.webp</url>
<title>Acrux Ltd</title>
<link>https://6ix.com/company/acrux-ltd</link>
</image>
<item>
<title>Australian company unlocks a new era for women's health globally with an innovative delivery system for Female testosterone in women with low libido</title>
<link>https://6ix.com/company/acrux-ltd/news/australian-company-unlocks-a-new-era-for-womens-health-globally-with-an-innovative-delivery-system-for-female-testosterone-in-women-with-low-libido</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/australian-company-unlocks-a-new-era-for-womens-health-globally-with-an-innovative-delivery-system-for-female-testosterone-in-women-with-low-libido</guid>
<pubDate>Tue, 28 Apr 2026 06:25:00 GMT</pubDate>
<description>Acrux is a successful Australian pharmaceutical company that develops innovative drugs for the global market. It recently announced its new strategy to enter the final, phase III clinical trial, stage of development for a Female Testosterone product. This continues the company's heritage in designing and developing patient-preferred drug delivery systems and it address a large unmet patient need. The unmet need is Hypoactive Sexual Desire Disorder (HSDD) or, in common English low libido or low s</description>
</item>
<item>
<title>Acrux receives $0.55m advance on FY26 R&D Tax Incentive</title>
<link>https://6ix.com/company/acrux-ltd/news/acrux-receives-dollar055m-advance-on-fy26-randd-tax-incentive</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/acrux-receives-dollar055m-advance-on-fy26-randd-tax-incentive</guid>
<pubDate>Thu, 12 Mar 2026 03:22:03 GMT</pubDate>
<description>Acrux receives $0.55m advance on FY26 R&D Tax Incentive</description>
</item>
<item>
<title>Half Yearly Report and Accounts</title>
<link>https://6ix.com/company/acrux-ltd/news/half-yearly-report-and-accounts-551</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/half-yearly-report-and-accounts-551</guid>
<pubDate>Wed, 25 Feb 2026 03:57:06 GMT</pubDate>
<description>Half Yearly Report and Accounts</description>
</item>
<item>
<title>Quarterly Activities/Appendix 4C Cash Flow Report</title>
<link>https://6ix.com/company/acrux-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-305</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-305</guid>
<pubDate>Thu, 29 Jan 2026 03:15:08 GMT</pubDate>
<description>Quarterly Activities/Appendix 4C Cash Flow Report</description>
</item>
<item>
<title>Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream</title>
<link>https://6ix.com/company/acrux-ltd/news/divestment-of-prilocaine-25percent-and-lidocaine-25percent-cream</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/divestment-of-prilocaine-25percent-and-lidocaine-25percent-cream</guid>
<pubDate>Fri, 12 Dec 2025 03:47:05 GMT</pubDate>
<description>Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream</description>
</item>
<item>
<title>AGM Presentation and Address</title>
<link>https://6ix.com/company/acrux-ltd/news/agm-presentation-and-address</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/agm-presentation-and-address</guid>
<pubDate>Tue, 25 Nov 2025 02:58:15 GMT</pubDate>
<description>AGM Presentation and Address</description>
</item>
<item>
<title>Acrux receives $0.4m advance on FY26 R&D Tax Incentive</title>
<link>https://6ix.com/company/acrux-ltd/news/acrux-receives-dollar04m-advance-on-fy26-randd-tax-incentive</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/acrux-receives-dollar04m-advance-on-fy26-randd-tax-incentive</guid>
<pubDate>Thu, 13 Nov 2025 02:42:08 GMT</pubDate>
<description>Acrux receives $0.4m advance on FY26 R&D Tax Incentive</description>
</item>
<item>
<title>Received $3.04m RDTI rebate for FY25</title>
<link>https://6ix.com/company/acrux-ltd/news/received-dollar304m-rdti-rebate-for-fy25</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/received-dollar304m-rdti-rebate-for-fy25</guid>
<pubDate>Thu, 04 Sep 2025 02:44:24 GMT</pubDate>
<description>Received $3.04m RDTI rebate for FY25</description>
</item>
<item>
<title>Appendix 4E and Full Year Statutory Accounts FY25</title>
<link>https://6ix.com/company/acrux-ltd/news/appendix-4e-and-full-year-statutory-accounts-fy25</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/appendix-4e-and-full-year-statutory-accounts-fy25</guid>
<pubDate>Fri, 29 Aug 2025 03:18:31 GMT</pubDate>
<description>Appendix 4E and Full Year Statutory Accounts FY25</description>
</item>
<item>
<title>Licensing partnership in Saudi Arabia for Dapsone 5%, Gel</title>
<link>https://6ix.com/company/acrux-ltd/news/licensing-partnership-in-saudi-arabia-for-dapsone-5percent-gel</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/licensing-partnership-in-saudi-arabia-for-dapsone-5percent-gel</guid>
<pubDate>Thu, 31 Jul 2025 03:21:39 GMT</pubDate>
<description>Licensing partnership in Saudi Arabia for Dapsone 5%, Gel</description>
</item>
<item>
<title>Receipt of second advance for FY25 R&D Tax Incentive</title>
<link>https://6ix.com/company/acrux-ltd/news/receipt-of-second-advance-for-fy25-randd-tax-incentive</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/receipt-of-second-advance-for-fy25-randd-tax-incentive</guid>
<pubDate>Thu, 03 Jul 2025 03:49:20 GMT</pubDate>
<description>Receipt of second advance for FY25 R&D Tax Incentive</description>
</item>
<item>
<title>Dapsone 7.5%, Gel launched in the United States</title>
<link>https://6ix.com/company/acrux-ltd/news/dapsone-75percent-gel-launched-in-the-united-states</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/dapsone-75percent-gel-launched-in-the-united-states</guid>
<pubDate>Fri, 09 May 2025 02:53:15 GMT</pubDate>
<description>Dapsone 7.5%, Gel launched in the United States</description>
</item>
<item>
<title>Acrux CEO and Managing Director appointment</title>
<link>https://6ix.com/company/acrux-ltd/news/acrux-ceo-and-managing-director-appointment</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/acrux-ceo-and-managing-director-appointment</guid>
<pubDate>Wed, 07 May 2025 03:33:18 GMT</pubDate>
<description>Acrux CEO and Managing Director appointment</description>
</item>
<item>
<title>Acrux receives $1.73m advance on FY25 R&D Tax Incentive</title>
<link>https://6ix.com/company/acrux-ltd/news/acrux-receives-dollar173m-advance-on-fy25-randd-tax-incentive</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/acrux-receives-dollar173m-advance-on-fy25-randd-tax-incentive</guid>
<pubDate>Thu, 03 Apr 2025 02:53:18 GMT</pubDate>
<description>Acrux receives $1.73m advance on FY25 R&D Tax Incentive</description>
</item>
<item>
<title>Investor Presentation February 2025</title>
<link>https://6ix.com/company/acrux-ltd/news/investor-presentation-february-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/investor-presentation-february-2025-1</guid>
<pubDate>Tue, 25 Feb 2025 11:15:10 GMT</pubDate>
<description>Investor Presentation February 2025</description>
</item>
<item>
<title>Appendix 4D and December 2024 Half Year Accounts</title>
<link>https://6ix.com/company/acrux-ltd/news/appendix-4d-and-december-2024-half-year-accounts</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/appendix-4d-and-december-2024-half-year-accounts</guid>
<pubDate>Tue, 25 Feb 2025 11:11:05 GMT</pubDate>
<description>Appendix 4D and December 2024 Half Year Accounts</description>
</item>
<item>
<title>Acrux CEO announces plan to retire</title>
<link>https://6ix.com/company/acrux-ltd/news/acrux-ceo-announces-plan-to-retire</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/acrux-ceo-announces-plan-to-retire</guid>
<pubDate>Fri, 07 Feb 2025 03:56:04 GMT</pubDate>
<description>Acrux CEO announces plan to retire</description>
</item>
<item>
<title>Monthly Activities/Appendix 4C Cash Flow Report</title>
<link>https://6ix.com/company/acrux-ltd/news/monthly-activitiesappendix-4c-cash-flow-report-26</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/monthly-activitiesappendix-4c-cash-flow-report-26</guid>
<pubDate>Thu, 30 Jan 2025 03:02:16 GMT</pubDate>
<description>Monthly Activities/Appendix 4C Cash Flow Report</description>
</item>
<item>
<title>Launch of 90 gram pack size of Dapsone 5%, Gel in US</title>
<link>https://6ix.com/company/acrux-ltd/news/launch-of-90-gram-pack-size-of-dapsone-5percent-gel-in-us</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/launch-of-90-gram-pack-size-of-dapsone-5percent-gel-in-us</guid>
<pubDate>Thu, 16 Jan 2025 03:12:15 GMT</pubDate>
<description>Launch of 90 gram pack size of Dapsone 5%, Gel in US</description>
</item>
<item>
<title>Acrux raises $1.34 million from SPP</title>
<link>https://6ix.com/company/acrux-ltd/news/acrux-raises-dollar134-million-from-spp</link>
<guid isPermaLink="true">https://6ix.com/company/acrux-ltd/news/acrux-raises-dollar134-million-from-spp</guid>
<pubDate>Mon, 23 Dec 2024 03:05:11 GMT</pubDate>
<description>Acrux raises $1.34 million from SPP</description>
</item>
</channel>
</rss>